Recent RWE Data Show Cell-Based Influenza Vaccines Offer 20% Greater Protection in the Prevention of Test-Confirmed Influenza in Pediatric and Adult Populations Relative to Standard Egg-Based Influenza Vaccines

— Real-world evidence (RWE) data estimate 19.8% relative vaccine effectiveness (rVE) of cell-based quadrivalent influenza vaccines (QIVc) versus standard egg-based quadrivalent vaccines (QIVe) in the prevention of test-confirmed influenza during the 2023/24 U.S. season for populations six months to 64 years.1 — Consistent rVE results were observed for pediatric, adult, outpatient and high-risk subgroups.1 — […]

Krell Technologies Named Innovator of the Year at 2025 New Jersey Manufacturing Awards

Krell Technologies, a leading manufacturer of precision polishing and inspection systems for photonic components, has been recognized as Innovator of the Year at the 2025 New Jersey Manufacturing Awards, hosted by the New Jersey Manufacturing Extension Program (NJMEP). The annual event brought together thousands of manufacturers, business leaders, and policymakers from across the state to

Baird Medical Fosters Advanced Physician Training at International Thyroid Microwave Ablation Workshop in Malaysia

Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its successful participation in the Thyroid Microwave Ablation Workshop held at the Hospital Canselor Tuanku Muhriz (HCTM) of The National University of Malaysia. https://mma.prnewswire.com/media/2801159/Baird_malaysia.jpg The immersive two-day workshop, held from October 1-2, 2025, brought together leading

Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market

NetworkNewsWire Editorial Coverage Artificial intelligence (AI) is making inroads into every corner of medical technology, perhaps none more urgently than imaging. In breast cancer detection, where early diagnosis can mean the difference between life and death, AI-enhanced modalities present a chance to leap beyond the limits of mammography,tomosynthesis, and MRI. Globally, breast cancer remains one

AudioEye Sets Third Quarter 2025 Earnings Call

AudioEye, Inc.(Nasdaq: AEYE) (“AudioEye” or the “Company”), the industry-leading digital accessibility company, will hold a conference call on Tuesday, November 4, 2025 at 4:30 p.m. Eastern Time to discuss its financial results for the third quarter ended September 30, 2025. Financial results will be issued in a press release prior to the call. https://mma.prnewswire.com/media/1470477/AudioEye_v3_Logo.jpg AudioEye

374Water Completes Commercial-Scale Field Demonstration for DoD ESTCP/DIU Project

374Water Completes Commercial-Scale Field Demonstration for DoD ESTCP/DIU Project GlobeNewswire October 21, 2025 Executed PFAS Destruction of Multiple Concentrated Waste Streams at Commercial TSDF using AirSCWO(TM) 6 System Final Report to be Released by Q1 2026 DURHAM, N.C., Oct. 21, 2025 (GLOBE NEWSWIRE) — 374Water Inc. (NASDAQ: SCWO) (“374Water” or the “Company”), a global leader

MEDIA ADVISORY: Foxit to Attend EDUCAUSE 2025

Discover how Foxit's intelligent PDF and eSignature tools help educators, administrators, and students simplify workflows, boost collaboration, and accelerate digital learning Foxit, a leading provider of innovative PDF and eSignature products and services that help knowledge workers increase productivity and do more with documents, will showcase its latest education-focused document solutions at EDUCAUSE 2025. https://mma.prnewswire.com/media/2620217/new_foxit_Logo_2025.jpg

Revalesio to Present RNS60 !!!!12-Hour Data from the Phase 2 RESCUE Trial in Acute Ischemic Stroke at World Stroke Congress 2025

Revalesio, a clinical-stage pharmaceutical company pioneering neuroprotective therapies for neurological disorders, today announced that data from a post hoc analysis of the RESCUE Phase 2 clinical trial of its investigational drug RNS60 will be featured as one of two promising drug candidates for the treatment of stroke in an upcoming session at the 17th World

Talphera Announces the Appointment of Joe Todisco to Board of Directors

Talphera, Inc.(Nasdaq: TLPH), (Talphera), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the appointment of Joe Todisco, the CEO of CorMedix Inc. (Nasdaq: CRMD) to its Board of Directors. In September 2025, CorMedix made a strategic investment in Talphera as part of

New ePlus AI Industry Pulse Poll Reveals Strategic Shift: AI Moves from Efficiency to Expansion

Nearly Three Out of Four IT and Industry Leaders Now Prioritize Revenue Growth as Main Driver of AI Initiatives, Over Cost Savings and Increased Customer Satisfaction ePlus inc. (NASDAQ: PLUS) today announced the findings of its new AI Industry Pulse Poll, which offers a closer look at how organizational leaders are reimagining the role of

Scroll to Top